The path to improved safety of gene-based products
Drug Discovery World
MAY 11, 2023
Another dangerous consequence can occur when the therapeutic or vaccine introduces proteins that can activate an uncontrolled immune response. In the case of therapeutics, the aim is usually to avoid patients’ immune responses. LC-MS can prove valuable not only in quality control, but also in early development phases.
130 
Let's personalize your content